top of page

Topic

Hepatocellular Carcinoma (HCC)

59 Podcasts • 18 Cases • 5 Courses on BackTable

Hear how experienced physicians manage Hepatocellular Carcinoma (HCC) on BackTable. Learn from podcasts, cases, and courses curated by physician content creators, covering diagnosis, clinical decision-making, and treatments. Get the BackTable app to follow this Topic and hear more of the conversations that matter to your practice.

Microwave Ablation for Liver Tumors: Techniques & Outcomes
00:00 / 01:04

Save your progress. Continue watching on the BackTable app.

BackTable Vascular & Interventional

Episode # 577  •  30 Sept 2025

Microwave Ablation for Liver Tumors: Techniques & Outcomes

Is microwave ablation only for simple liver tumors, or can it be a versatile ‘Swiss Army knife’ for a wide range of complex cases? In this episode, Dr. Driss Raissi of the University of Kentucky returns to BackTable to join host Dr. Chris Beck for a deep dive into advanced and unconventional microwave ablation techniques. They cover strategies for tackling a wide range of cases, from desmoid tumors to enterocutaneous fistulas.

This podcast is supported by an educational grant from Medtronic.

More on Hepatocellular Carcinoma (HCC)

Loading recent podcasts…

VI

VI Episode #577

Sep 30, 2025

with Dr. Driss Raissi, Dr. Christopher Beck

Microwave Ablation for Liver Tumors: Techniques & Outcomes

Is microwave ablation only for simple liver tumors, or can it be a versatile ‘Swiss Army knife’ for a wide range of...

2,000+ listens

VI

VI Episode #561

Jul 29, 2025

with Dr. Tyler Sandow, Dr. Zach Berman, Dr. Venkatesh Krishnasamy

Dosimetry University VI: Challenging Case Review

When is Y90 the right treatment for metastatic disease? Join Drs. Tyler Sandow, Zach Berman and host Kavi Krishnasamy...

1,900+ listens

VI

VI Episode #556

Jul 8, 2025

with Dr. Tyler Sandow, Dr. Zach Berman, Dr. Venkatesh Krishnasamy

Dosimetry University Part IV: Optimizing Radiation Segmentectomy

Radiation segmentectomy: who, when, how? Interventional oncologists Dr. Nima Kokabi, Dr. Tyler Sandow, and Dr. Kavi...

1,800+ listens

VI

VI Episode #553

Jun 24, 2025

with Dr. Tyler Sandow, Dr. Nima Kokabi, Dr. Venkatesh Krishnasamy

Dosimetry University Part II: Understanding Partition & Voxel-Based Approaches

BSA, MIRD, or voxel-based dosimetry? Join us for part 2 of Dosimetry University where interventional oncologists Dr....

2,600+ listens

VI

VI Episode #564

Aug 12, 2025

with Dr. Zach Berman, Dr. Christopher Beck

Pressure-Enabled Drug Delivery in HCC & Metastatic Liver Lesions

Can you manipulate blood flow in the tumor microenvironment to optimize drug delivery? In this episode of the BackTable...

2,300+ listens

VI

VI Episode #559

Jul 22, 2025

with Dr. Tyler Sandow, Dr. Zach Berman, Dr. Venkatesh Krishnasamy

Dosimetry University V: Case Review on Dose Optimization Strategies

The balance between targeting tumor and sparing healthy liver is delicate. How do the experts do it? In this case-based...

1,600+ listens

VI

VI Episode #555

Jul 1, 2025

with Dr. Nima Kokabi, Dr. Tyler Sandow, Dr. Venkatesh Krishnasamy

Dosimetry University Part III: Optimizing Single-Session Treatments

Will single session Y90 become the standard of care for HCC and oligo-metastatic disease? Tune in to our third...

2,500+ listens

VI

VI Episode #552

Jun 17, 2025

with Dr. Nima Kokabi, Dr. Tyler Sandow, Dr. Venkatesh Krishnasamy

Dosimetry University Part I: Treatment Planning

Dosimetry University is now in session! First up—how do you plan your Y90 treatments and what can you do in the...

3,400+ listens

VI

VI Case

Jan 22, 2025

HCC: Surgical & Non-Surgical Treatments for a 60-year Old with Solitary LR5

with Dr. Gabriel Schnickel, Dr. Adam Burgoyne, Dr. Heather Patton, Dr. Siddharth Padia and Dr. Zach Berman

VI

VI Case

Jan 22, 2025

HCC: Multifocal Disease in a Non-Cirrhotic Patient

with Dr. Gabriel Schnickel, Dr. Adam Burgoyne, Dr. Heather Patton, Dr. Siddharth Padia and Dr. Zach Berman

VI

VI Case

Jan 22, 2025

HCC: 78-year Old Male with Ruptured Lesion

with Dr. Gabriel Schnickel, Dr. Adam Burgoyne, Dr. Heather Patton, Dr. Siddharth Padia and Dr. Zach Berman

VI

VI Case

Jan 22, 2025

HCC: 61-year Old Male with Portal Vein Involvement

with Dr. Gabriel Schnickel, Dr. Adam Burgoyne, Dr. Heather Patton, Dr. Siddharth Padia and Dr. Zach Berman

VI

VI Case

Jan 22, 2025

HCC: 68-year Old Non-Cirrhotic Patient with an LR5 Lesion

with Dr. Gabriel Schnickel, Dr. Adam Burgoyne, Dr. Heather Patton, Dr. Siddharth Padia and Dr. Zach Berman

VI

VI Case

Jan 22, 2025

HCC: 67-year Old with Cirrhosis, pHTN, 10cm Lesion

with Dr. Gabriel Schnickel, Dr. Adam Burgoyne, Dr. Heather Patton, Dr. Siddharth Padia and Dr. Zach Berman

VI

VI Case

Jan 22, 2025

HCC: 64-year Old with Multifocal Disease: Immunotherapy? Transplant?

with Dr. Gabriel Schnickel, Dr. Adam Burgoyne, Dr. Heather Patton, Dr. Siddharth Padia and Dr. Zach Berman

VI

VI Case

Jan 22, 2025

HCC: 78-year Old Presenting Post Transplant with Adrenal Metastases

with Dr. Gabriel Schnickel, Dr. Adam Burgoyne, Dr. Heather Patton, Dr. Siddharth Padia and Dr. Zach Berman

Multidisciplinary Approach & Combination Therapies for HCC

Tumor Board Course

2 CME/CE credits, 2 hours, 20 lessons

Y90 Dosing & Ablation Modalities for HCC

Tumor Board Course

2 CME/CE credits, 2 hours, 20 lessons

Endovascular Management of HCC

VI Course

2 hours, 37 lessons

IR, Surgical & Transplant Collaboration for HCC

Tumor Board Course

2 CME/CE credits, 2 hours, 22 lessons

Medtronic was not involved in the creation or delivery of any program content and does not control whether the materials conform to an FDA approved or cleared indication.

The Materials available on BackTable are provided for informational and educational purposes only and are not a substitute for the independent professional judgment of a qualified healthcare professional in diagnosing or treating patients. Any opinions, statements, or views expressed are those of the individual contributors and do not necessarily reflect those of the publisher, platform, or any affiliated organization.

bottom of page